Axcella to Present at Upcoming Investor Conferences
February 18 2021 - 7:55AM
Business Wire
Webcasts scheduled for February 26, March 9 and
March 15
Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company
pioneering a new approach to treat complex diseases and improve
health using endogenous metabolic modulator (EMM) compositions,
today announced that management will participate in the following
upcoming investor conferences:
- SVB Leerink 10th Annual Global Healthcare Conference:
The company’s fireside chat will be webcast on February 26, 2021 at
9:20 a.m. ET.
- H.C. Wainwright Global Life Sciences Conference: The
company’s presentation will be webcast on March 9, 2021 at 7:00
a.m. ET.
- 33rd Annual Roth Conference: The company’s fireside chat
will be webcast on March 15, 2021 at 9:00 a.m. ET.
The audio webcasts will be accessible on the “Investors &
News” section of the company’s website, www.axcellahealth.com, for
90 days following the presentations.
Internet Posting of Information
Axcella uses its website, www.axcellahealth.com, as a means of
disclosing material nonpublic information and for complying with
its disclosure obligations under Regulation FD. Such disclosures
will be included on the company’s website in the “Investors and
News” section. Accordingly, investors should monitor this portion
of the company’s website, in addition to following its press
releases, SEC filings and public conference calls and webcasts.
About Axcella
Axcella is a clinical-stage biotechnology company pioneering a
new approach to treat complex diseases and improve health using
endogenous metabolic modulator (EMM) compositions. The company’s
product candidates are comprised of EMMs and their derivatives that
are engineered in distinct combinations and ratios to
simultaneously impact multiple biological pathways. Axcella’s
pipeline includes lead therapeutic candidates for non-alcoholic
steatohepatitis (NASH) and the reduction in risk of overt hepatic
encephalopathy (OHE) recurrence. For more information, please visit
www.axcellahealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210218005026/en/
Jason Fredette jfredette@axcellahealth.com 857.320.2236
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From Sep 2023 to Sep 2024